Paper4600587
Hyperactive children. A continuous long-term placebo-controlled follow-up.
Sleator EK and 2 others. JAMA, 1974. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Hyperactive children. A continuous long-term placebo-controlled follow-up. Papers, record 4600587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4600587
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dextroamphetamine | Major topic |
| Hyperkinesis | Major topic |
| Methylphenidate | Major topic |
| Age Factors | |
| Child | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Follow-Up Studies | |
| Humans | |
| Placebos | |
| Remission, Spontaneous | |
| School Health Services | |
| Sulfates | |
| Surveys and Questionnaires | |
| Time Factors |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33959050 | Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis. | Front Psychiatry | 2021 | https://conductscience.org/library/papers/33959050 | PubMed |
| 27520752 | Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective. | CNS Drugs | 1997 | https://conductscience.org/library/papers/27520752 | PubMed |
| 26844979 | Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26844979 | PubMed |
| 21234056 | Treating attention deficit disorder. | Can Fam Physician | 1990 | https://conductscience.org/library/papers/21234056 | PubMed |
| 6151937 | Use of drugs in child psychiatry. | Indian J Pediatr | 1984 | https://conductscience.org/library/papers/6151937 | PubMed |
| 6146156 | The persistence of stimulant effects in chronically treated children: further evidence of an inverse relationship between drug effects and placebo levels of response. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6146156 | PubMed |
| 1030661 | The hyperkinetic child syndrome: the need for reassessment. | Child Psychiatry Hum Dev | 1976 | https://conductscience.org/library/papers/1030661 | PubMed |
| 1002950 | Assessment of a cognitive training program for hyperactive children. | J Abnorm Child Psychol | 1976 | https://conductscience.org/library/papers/1002950 | PubMed |
| 6240 | Medication for hyperkinetic children. | Drugs | 1976 | https://conductscience.org/library/papers/6240 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4600587
GET https://conductscience.org/api/papers/v1/4600587/authors